Medicine:Thrombin generation assay
| Thrombin generation assay | |
|---|---|
| Medical diagnostics | |
| Synonyms | TGA; Thrombin generation test; TGT |
| Test of | Thrombin generation, coagulation, hypercoagulability |
A thrombin generation assay (TGA) or thrombin generation test (TGT) is a global coagulation assay (GCA) and type of coagulation test which can be used to assess coagulation and thrombotic risk.[1][2][3] It is based on the potential of a plasma to generate thrombin over time, following activation of coagulation via addition of phospholipids, tissue factor, and calcium.[4] The results of the TGA can be output as a thrombogram or thrombin generation curve using computer software with calculation of thrombogram parameters.[5][1]
TGAs can be performed with methods like the semi-automated calibrated automated thrombogram (CAT) (2003) or the fully-automated ST Genesia system (2018).[6][1][7] TGAs were first used as manual assays in the 1950s and have since become increasingly automated.[1]
Parameters
Thrombogram parameters for the TGA include:[1]
- Lag time (minutes; time until thrombin first generated/thrombin concentration first increased)
- Time to peak or ttPeak (minutes; time to maximum concentration of thrombin generated)
- Start tail (minutes; time at which thrombin generation ends and all generated thrombin has been inhibited)
- Peak height or peak thrombin (molar concentration (e.g., nM) of thrombin; peak or maximum concentration of thrombin generated)
- Velocity index (slope of thrombin generation between lag time/first thrombin generation and time to peak; corresponds to first derivative of this part of curve)
- Endogenous thrombin potential (ETP; area under the curve of the thrombin generation curve)
ETP-based APC resistance test
The addition of activated protein C (APC) to a TGA results in an inhibition of thrombin generation as measured by reduction of the endogenous thrombin potential (ETP; area under the thrombin generation curve).[4] This can be used to assess APC resistance and is termed the ETP-based APC resistance test.[4] Results may be expressed as normalized APC sensitivity ratio (nAPCsr), which corresponds to the ratio of the ETP measured in the presence and absence of APC divided by the same ratio in reference plasma.[4] The higher the nAPCsr value, the greater the APC resistance of the person.[4] The ETP-based APC resistance test was developed in 1997.[4]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 "Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine". J Thromb Haemost 19 (12): 2907–2917. December 2021. doi:10.1111/jth.15529. PMID 34525255.
- ↑ "Clinical use of thrombin generation assays". J Thromb Haemost 19 (12): 2918–2929. December 2021. doi:10.1111/jth.15538. PMID 34592058.
- ↑ "Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations". Rev Bras Hematol Hemoter 39 (3): 259–265. 2017. doi:10.1016/j.bjhh.2017.03.009. PMID 28830606.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 "Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk". Front Endocrinol (Lausanne) 12: 769187. 2021. doi:10.3389/fendo.2021.769187. PMID 34956081.
- ↑ "Thrombin Generation Assay and Its Application in the Clinical Laboratory". Clin Chem 62 (5): 699–707. May 2016. doi:10.1373/clinchem.2015.248625. PMID 26955824.
- ↑ "Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?". Hamostaseologie 40 (3): 364–378. August 2020. doi:10.1055/a-1153-5824. PMID 32726831.
- ↑ "A review of commercially available thrombin generation assays". Res Pract Thromb Haemost 2 (1): 42–48. January 2018. doi:10.1002/rth2.12048. PMID 30046705.
 |  |
